Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1990-8-14
|
| pubmed:abstractText |
Increasing interest is being shown in the antituberculous drug pyrazinamide. An in-vitro model using cultures of human blood macrophages was tested with 8 different Mycobacterium tuberculosis trains. A good correlation was found between the susceptibility of the strains to pyrazinamide and the Kinetics in the macrophage culture.
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0934-8387
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
44 Suppl 1
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
460-1
|
| pubmed:dateRevised |
2009-4-7
|
| pubmed:meshHeading | |
| pubmed:year |
1990
|
| pubmed:articleTitle |
[Determination of the sensitivity of tuberculosis bacteria to pyrazinamide using human macrophage culture].
|
| pubmed:affiliation |
Webb-Waring Lung Institute, University of Colorado Health Sciences Center, Denver.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|